Issam Makhoul Selected Research

Issam Makhoul Research Topics

Disease

35	Neoplasms (Cancer) 10/2022 - 09/2009
31	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2009
9	Cardiotoxicity 12/2021 - 01/2012
6	Melanoma (Melanoma, Malignant) 01/2020 - 01/2016
5	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2009
5	Pathologic Complete Response 01/2020 - 03/2011
2	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 06/2013
2	Infections 08/2023 - 10/2022
2	Inflammation (Inflammations) 01/2020 - 03/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2012
2	Adenocarcinoma 12/2017 - 03/2015
2	Ductal Carcinoma 01/2016 - 02/2015
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Hyperglycemia 11/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2021
1	Osteoporosis 05/2020
1	Vitamin D Deficiency 05/2020
1	Body Weight (Weight, Body) 02/2020
1	Thrombophilia 01/2020
1	Bone Diseases (Bone Disease) 10/2019
1	Femoral Fractures (Femoral Fracture) 10/2019
1	Cholangiocarcinoma 11/2018
1	Neoplasm Micrometastasis 04/2018
1	Pulmonary Hypertension 04/2018
1	Upper Extremity Deep Vein Thrombosis 01/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2012
10	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 01/2012
5	AntibodiesIBA 10/2022 - 01/2015
5	Bevacizumab (Avastin)FDA Link 01/2020 - 06/2013
4	MicroRNAs (MicroRNA)IBA 08/2023 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2018
3	Hormones (Hormone)IBA 01/2022 - 02/2015
3	Estrogen ReceptorsIBA 01/2021 - 02/2015
3	NivolumabIBA 01/2020 - 01/2016
3	VaccinesIBA 01/2020 - 01/2015
3	CarbohydratesIBA 01/2020 - 01/2015
2	AntigensIBA 10/2022 - 01/2020
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 10/2019
2	human ERBB2 proteinIBA 01/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 12/2020 - 04/2017
2	pembrolizumabIBA 01/2020 - 04/2017
2	Peptides (Polypeptides)IBA 01/2020 - 01/2015
2	von Willebrand FactorIBA 01/2020 - 02/2015
2	IpilimumabIBA 01/2020 - 04/2017
2	Monoclonal AntibodiesIBA 01/2018 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 09/2017 - 01/2012
1	Radioisotopes (Radionuclides)IBA 01/2023
1	Cancer VaccinesIBA 10/2022
1	Polysaccharides (Glycans)IBA 10/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	hydroxide ionIBA 01/2022
1	Denosumab FDA Link 01/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	AlpelisibIBA 11/2021
1	Insulin (Novolin)FDA Link 11/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Combined VaccinesIBA 10/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	ribociclibIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Growth Factor ReceptorsIBA 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Vitamin D FDA LinkGeneric 05/2020
1	Troponin IIBA 02/2020
1	2,6-dinitrotoluene (DNT)IBA 02/2020
1	Dantrolene (Dantrium)FDA LinkGeneric 02/2020
1	CalciumIBA 02/2020
1	P-SelectinIBA 01/2020
1	antithrombin III-protease complexIBA 01/2020
1	N 30IBA 01/2020
1	peptide AIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Nucleosomes (Nucleosome)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	ThrombomodulinIBA 01/2020
1	Melanins (Melanin)IBA 12/2019
1	Cetuximab (Erbitux)FDA Link 07/2019
1	Ephrin-B2 (Ephrin B2)IBA 11/2018
1	erucylphosphocholineIBA 11/2018
1	LigandsIBA 11/2018
1	CytokinesIBA 01/2018
1	Troponin T (Troponin T1)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	SilverIBA 12/2017
1	GoldIBA 12/2017

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 12/2021 - 01/2012
17	Therapeutics 10/2022 - 09/2009
7	Immunotherapy 10/2022 - 01/2015
7	Neoadjuvant Therapy 01/2022 - 03/2011
1	Radiotherapy 12/2020
1	Lasers (Laser) 12/2019
1	Terminal Care (Care, Terminal) 07/2018
1	Aftercare (After-Treatment) 04/2018
1	Vascular Access Devices (Arterial Line) 01/2018